Molecular portraits of human breast tumours, Nature, vol.406, pp.747-752, 2000. ,
Gene expression correlates of clinical prostate cancer behavior Cancer Cell, vol.1, pp.203-209, 2002. ,
Gene expression profiling predicts clinical outcome of breast cancer Nature, vol.415, pp.530-536, 2002. ,
Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer Jama, vol.280, pp.969-974, 1998. ,
Expression signatures that correlated with Gleason score and relapse in prostate cancer Genomics, vol.89, pp.666-672, 2007. ,
mRNA expression signature of Gleason grade predicts lethal prostate cancer, Journal of Clinical Oncology, vol.29, p.2391, 2011. ,
Prognostic utility of a new mRNA expression signature of Gleason score Clinical Cancer Research, vol.23, pp.81-87, 2017. ,
Gene expression signature of Gleason score is associated with prostate cancer outcomes in a radical prostatectomy cohort, Oncotarget, vol.8, p.43035, 2017. ,
Gene Expression Profiling in Clinically Localized Prostate Cancer: A Four-Gene Expression Model Predicts Clinical Behavior Clinical Cancer Research, vol.9, pp.5477-5485, 2003. ,
Global Transcriptome Analysis of Formalin-Fixed Prostate Cancer Specimens Identifies Biomarkers of Disease Recurrence Cancer Research, vol.74, pp.3228-3237, 2014. ,
Whole-genome and transcriptome sequencing of prostate cancer identify new genetic alterations driving disease progression, European urology, vol.73, pp.322-339, 2018. ,
The proteogenomic landscape of curable prostate cancer Cancer Cell, vol.35, pp.414-427, 2019. ,
Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy PloS one, vol.8, p.66855, 2013. ,
Validation of a Genomic Classifier that Predicts Metastasis Following Radical Prostatectomy in an At Risk Patient Population, Journal of Urology, vol.190, pp.2047-2053, 2013. ,
A genomic classifier improves prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapy, European Urology, vol.67, pp.778-786, 2015. ,
Novel Gene Expression Signature Predictive of Clinical Recurrence After Radical Prostatectomy in Early Stage Prostate Cancer Patients The Prostate, vol.76, pp.1239-1256, 2016. ,
Bridging the gap between reference and real transcriptomes Genome biology, vol.20, pp.1-7, 2019. ,
DE-kupl: exhaustive capture of biological variation in RNA-seq data through k-mer decomposition, Genome Biology, vol.18, p.243, 2017. ,
Reference-free transcriptome exploration reveals novel RNAs for prostate cancer diagnosis Life Science Alliance, vol.2, pp.1-12, 2019. ,
GECKO is a genetic algorithm to classify and explore high throughput sequencing data, Communications Biology, vol.2, p.222, 2019. ,
Prediction of cancer outcome with microarrays: a multiple random validation strategy The Lancet, vol.365, pp.488-492, 2005. ,
Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer, Proceedings of the National Academy of Sciences, vol.103, pp.5923-5928, 2006. ,
Interpretation of microarray data in cancer, British Journal of Cancer, vol.96, pp.1155-1158, 2007. ,
Most random gene expression signatures are significantly associated with breast cancer outcome, PLoS computational biology, vol.7, p.1002240, 2011. ,
The molecular taxonomy of primary prostate cancer Cell, vol.163, pp.1011-1025, 2015. ,
Genomic hallmarks of localized, non-indolent prostate cancer, Nature, vol.541, pp.359-364, 2017. ,
Integrative epigenetic taxonomy of primary prostate cancer, Nature communications, vol.9, pp.1-12, 2018. ,
An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics Cell, vol.173, pp.400-416, 2018. ,
Selection bias in gene extraction on the basis of microarray gene-expression data, Proceedings of the National Academy of Sciences, vol.99, pp.6562-6566, 2002. ,
A fast, lock-free approach for efficient parallel counting of occurrences of k-mers, Bioinformatics, vol.27, pp.764-770, 2011. ,
Melsted Páll, Pachter Lior. Near-optimal probabilistic RNA-seq quantification Nature biotechnology, vol.34, pp.525-527, 2016. ,
Mentekidis Yannis, Ghaisas Sumedh, Zhang Shangtong. mlpack 3: a fast, flexible machine learning library, Journal of Open Source Software, vol.3, p.726, 2018. ,
Regularization Paths for Generalized Linear Models via, Coordinate Descent Journal of Statistical Software, vol.33, pp.1-22, 2010. ,
Stability selection, Journal of the Royal Statistical Society: Series B (Statistical Methodology), vol.72, pp.417-473, 2010. ,
Building Predictive Models in R Using the caret, Package Journal of Statistical Software, Articles, vol.28, pp.1-26, 2008. ,
Hsapiens.v79: Ensembl based annotation package 2017 ,
Low CD38 identifies progenitor-like inflammation-associated luminal cells that can initiate human prostate cancer and predict poor outcome, Cell reports, vol.17, pp.2596-2606, 2016. ,
The tumor suppressive role of CAMK2N1 in castration-resistant prostate cancer, Oncotarget, vol.5, p.3611, 2014. ,
Collagen 1A1 (COL1A1) promotes metastasis of breast cancer and is a potential therapeutic target Discovery medicine, vol.25, pp.211-223, 2018. ,
GTSE1 promotes cell migration and invasion by regulating EMT in hepatocellular carcinoma and is associated with poor prognosis Scientific reports, vol.7, pp.1-12, 2017. ,
Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancer The Prostate, vol.73, pp.813-826, 2013. ,
Integrative genomics viewer, Nature biotechnology, vol.29, pp.24-30, 2011. ,
Identification of low-density lipoprotein receptor class A domain containing 4 (LDLRAD4) as a prognostic indicator in primary gastrointestinal stromal tumors Current Problems in Cancer, p.100593, 2020. ,
Antisense lncRNA LDLRAD4-AS1 promotes metastasis by decreasing the expression of LDLRAD4 and predicts a poor prognosis in colorectal cancer Cell death & disease, vol.11, pp.1-16, 2020. ,
Molecular determinants of resistance to antiandrogen therapy Nature medicine, vol.10, pp.33-39, 2004. ,
Loss of SPDEF and gain of TGFBI activity after androgen deprivation therapy promote EMT and bone metastasis of prostate cancer, Science Signaling, vol.10, p.6826, 2017. ,
Melchers Willem JG. Identification of a candidate gene panel for the early diagnosis of prostate cancer Clinical Cancer Research, vol.21, pp.3061-3070, 2015. ,
DD3: a new prostatespecific gene, highly overexpressed in prostate cancer, Cancer research, vol.59, pp.5975-5984, 1999. ,
Avgeris Margaritis, et al. L-dopa decarboxylase (DDC) gene expression is related to outcome in patients with prostate cancer BJU international, vol.110, pp.267-273, 2012. ,
A novel mechanism driving poor-prognosis prostate cancer: overexpression of the DNA repair gene, ribonucleotide reductase small subunit M2 (RRM2) Clinical Cancer Research, vol.25, pp.4480-4492, 2019. ,
Tumor Suppressor Role and Clinical Implication of the Fifth Ewing Variant (FEV) Gene, an ETS Family Gene, Prostate Cancer Prostate Cancer, 2019. ,
The cancer-associated cell migration protein TSPAN1 is under control of androgens and its upregulation increases prostate cancer cell migration Scientific reports, vol.7, pp.1-11, 2017. ,
HMGCS2 functions as a tumor suppressor and has a prognostic impact in prostate cancer Pathology-Research and Practice, vol.215, p.152464, 2019. ,
A 17-gene assay to predict prostate cancer aggressiveness in the context of gleason grade heterogeneity, tumor multifocality, and biopsy undersampling, European Urology, vol.66, pp.550-560, 2014. ,
Survival analysis with high-dimensional covariates Statistical Methods in Medical Research, vol.19, pp.29-51, 2010. ,
Identifying subgroup markers in heterogeneous populations, Nucleic Acids Research, vol.41, pp.200-200, 2013. ,
DECO: decompose heterogeneous population cohorts for patient stratification and discovery of sample biomarkers using omic data profiling, Bioinformatics, vol.35, pp.3651-3662, 2019. ,